Katherine E. McDonell

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere

Daniel O. Claassen, Katherine E. McDonell, Manus J. Donahue et al. · Brain and Behavior · 2016 · 119 citations · Full text

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Erin Furr Stimming, Daniel O. Claassen, Elise Kayson et al. · The Lancet Neurology · 2023 · 60 citations

Placebo-controlled Trial, Rehabilitation, Neurology +2

Motor speech patterns in Huntington disease

Sarah Diehl, Antje S. Mefferd, Ya‐Chen Lin et al. · Neurology · 2019 · 37 citations · Full text

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ralf Reilmann, Karen E. Anderson, Andrew Feigin et al. · The Lancet Neurology · 2024 · 29 citations · Full text

Clinical Trials, Rehabilitation, Neurology +2

Initiation of droxidopa during hospital admission for management of refractory neurogenic orthostatic hypotension in severely ill patients

Katherine E. McDonell, Brock A. Preheim, André Diedrich et al. · Journal of Clinical Hypertension · 2019 · 20 citations · Full text